| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 4.045 | 24.817 | 22.767 |
| Total Income - EUR | - | - | - | - | - | - | - | 4.045 | 24.817 | 22.767 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.677 | 10.533 | 11.169 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 2.369 | 14.284 | 11.597 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 2.250 | 11.827 | 9.158 |
| Employees | - | - | - | - | - | - | - | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Ana Maria Păvălan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 34.063 | 27.646 |
| Current Assets | - | - | - | - | - | - | - | 3.082 | 11.496 | 12.916 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 1.543 | 7.505 | 2.476 |
| Cash | - | - | - | - | - | - | - | 1.539 | 3.991 | 10.440 |
| Shareholders Funds | - | - | - | - | - | - | - | 2.290 | 14.110 | 23.190 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 792 | 31.449 | 17.929 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Ana Maria Păvălan S.r.l.